HepatoSys

HepatoSys Inc. was a biotechnology company dedicated to the restoration and resuscitation of human organs for therapeutic transplantation and research. Founded in 2005 as a spin-off from the University of North Carolina at Charlotte, the company developed a proprietary low-temperature machine perfusion technology designed to revive 'marginal' donor organs, such as those from donors after cardiac arrest. By utilizing a specialized liquid solution and non-invasive metabolic monitoring, HepatoSys aimed to expand the pool of viable organs for transplant by an estimated 20-40%. The company also provided high-quality human hepatocytes isolated from restored organs for use in pharmaceutical toxicity testing and academic research.